Journal
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
Volume 14, Issue 8, Pages 1024-1030Publisher
BENTHAM SCIENCE PUBL
DOI: 10.2174/1871527314666150326000018
Keywords
Mitochondrial biogenesis; Mitochondrial transcription factor A; Neurodegeneration; Parkinson's disease; Reactive oxygen species; Sirtuin 1
Categories
Funding
- DST, New Delhi [SR/CSI/49/2009]
Ask authors/readers for more resources
Mutations in mitochondrial genes, oxidative insults, imbalance in redox mechanisms and dysregulated mitophagy are some of the leading causes for mitochondrial dysfunction and subsequent neurodegeneration in Parkinson's disease. Targeting mitochondrial dysfunction and prolonging neuronal survival could potentially prove to be useful neuroprotective strategies. In some recent investigations, peroxisome proliferator activated receptor gamma coactivator 1 alpha mediated mitochondrial biogenesis and its ability to restore reactive oxygen species-detoxifying enzymes have been observed in preclinical studies. In this review, we discuss about physiological importance of peroxisome proliferator activated receptor gamma coactivator 1 alpha along with a list of its activators that could prove useful as possible neuroprotectants in Parkinson's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available